Rodrigo Erlich, MD

About Me

I am a medical oncologist who has been caring for people with cancer since 1996. I have special expertise in treating gastrointestinal (GI) cancers with chemotherapy, immunotherapy, and targeted biologic therapy. I also have extensive experience in caring for and addressing the unique needs of older people with cancer. My practice is located at MSK Basking Ridge, in New Jersey.

Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.

I was led to a career in oncology after admiring my father, who was a passionate physician and oncology pioneer in Latin America. He trained at MSK in the 1960s and I am proud to have followed in his footsteps.

My research has focused on a type of immunotherapy called immune checkpoint inhibitors. This newer type of treatment holds great promise for some people with GI cancers, particularly those with DNA mismatch repair deficiency.

When I meet with patients and their families, my goal is to provide them with the right amount of information to help them feel comfortable and confident in making their own decisions. We work together to weigh all options — including clinical trials and personalized therapies — to create a comprehensive plan. I am available for support and guidance every step of the way.

  • Clinical Expertise: Gastrointestinal Cancers; Chemotherapy, Immunotherapy, and Biological Targeted Therapy; Treatment of Elderly Cancer Patients
  • Languages Spoken: English; Portuguese; Spanish
  • Education: MD, Faculty of Medicine of Santa Casa de Sao Paulo, Brazil
  • Residencies: Internal Medicine & Medical Oncology – Internal Medical Institute, Brazil; Internal Medicine – University of Pittsburgh Medical Center
  • Fellowships: Cancer Research Fellowship - Mount Sinai Hospital, New York City; Medical Oncology/Hematology – University of Pittsburgh Medical Center & University of Pittsburgh Cancer Institute
  • Board Certifications: Hematology; Medical Oncology

New Patient Appointments

Making an appointment

Call 800-525-2225

Publications

“Therapeutic In Situ Autovaccination Against Solid Cancers with Intratumoral Poly-ICLC: Case Report, Hypothesis and Clinical Trial”. Salazar, AM, Erlich R, Mark A, Bhardwaj N, Herberman RB. Cancer Immunology Research, 2014;2 (8): 720-724.

“Novel Medical Therapies of Recurrent and Metastatic Gastroenteropancreatic Neuroendocrine Tumors”. Milijkovic, M, Girotra, M, Abraham, R., Erlich R. Digestive Diseases and Science 2012; 57(1):9-18.
“Cholangiocarcinoma: A Review and Update”. Olnes MJ, Erlich R. Oncology 2004; 66:167-179.

“Management of Squamous Cell Carcinoma of the Anus”. Erlich R, Hedlund SC. Cancer Practice 2002; 10(3):118-121.

Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.

“A Somatostatin Analogue (SMS 201-995) Alters the Toxicity of 5FU in Swiss Mice”. Lee, J.M., Erlich R, Bruckner HW, Szrajer L, Ohnuma T. Anticancer Research 1993; 13:1453-1456.

“Levamisole and the New Era of Chemoimmunotherapy”. Erlich R, Greenspan E M. Cancer Invest 1991; 9(1):111-124.

“Rectal Cancers: Adjuvant Therapy”. Erlich R. Chapter 32 of the book Cancer of the Colon, Rectum and Anus. Published by the Division of Colorectal Cancer at the A.C. Camargo Cancer Hospital-Treatment and Research Center, Sao Paulo, Brazil. Edited by Rossi and Lopes.

“Colorectal Cancer”. Erlich R. and Morrison C. Chapter 52 in the Johns Hopkins Internal Medicine Board Review. Edited by Bimal Ashar, Redonda Miller, Stephen Sisson. Publisher: Elsevier.

Clinical Trials

As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.

Learn more

Insurance

Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.

Learn more